ismagilov Skincare products maker Elevai Labs (ELAB) has filed to raise $6M through an IPO. Elevai said in a filing that it was looking to offer 1.5M shares at the assumed price of $4 per share. The company’s range, however, is $4 to $6 per share. The company hopes to list its shares on Nasdaq...
© armmypicca, 123RF Free Images Flipping houses can be a great way to turn a profit quickly and grow your wealth. However, investing in real estate often requires significant upfront capital. If you don’t have a lot of savings, you may be wondering how to flip houses with no money. Here are three strategies that...
ismagilov Carmot Therapeutics, which is developing drugs for diabetes and weight-loss, is reportedly mulling an IPO or possible sale to a large pharmaceutical company at a valuation of at least $1B. The biotech company has two injectable GLP-1 drug candidates in Phase 2 development for type 1 and type 2 diabetes, according to the company’s...
2d illustrations and photos Abivax (ABVX), a French developer of gastrointestinal drugs, has filed for a proposed $100M US IPO. The biotech company didn’t specify any terms in its SEC filing, but indicated in a filing fee schedule that it was seeking to raise around $100M, a figure that is likely a placeholder and subject...
In the coming years, electricity demand will grow at an accelerating pace, driven by the shift towards cleaner energy and transportation solutions, more frequent extreme weather conditions, and the growing use of disruptive technologies such as cryptocurrencies, streaming, and artificial intelligence. This means greater spending on networks, particularly to make the grid smarter and more...
Lately I’ve seen a lot of stories in financial media with headlines like, “This Millennial Makes $12,000/Month With Only 2 Hours Per Day of Work on Her Side Hustle,” or, “This Gen Z’er Earns $60,000 Per Year in Passive Income on Etsy.” There sure seem to be a lot of people making a boatload of...
Rising treasury bond yields have become a major headwind for stocks. This issue took center stage following the latest Fed dot plot that appeared to push back the starting point of the central bank’s eventual unwinding of its monetary policy tightening. As we have noted here before, we see the seemingly hawkish Fed posture as...
Mikko Lemola Lexeo Therapeutics (LXEO), a developer of genetic medicines, has filed for an initial public offering. Lexeo didn’t specify terms in its SEC filing, but indicated in an attached filing fee schedule that it was looking to raise $100M, a number that is likely a placeholder and subject to change. The company hopes to...
The World Federation of Exchanges (WFE) recently held its annual meeting, hosted by the Bermuda Stock Exchange and staged on the island from Sept. 19–21. We were both happy to represent Nasdaq, interacting with other industry leaders as the agenda highlighted overarching trends of regulation, innovation and market infrastructure transformation. Here are our top takeaways from...
Credit card debt can cut your retirement savings in half. A recent study penned by J.P. Morgan Asset Management and the Employee Benefit Research Institute examined how spending and credit card debt affects overall retirement savings. Each aspect of a household’s finances affect every other, so behavior in one aspect of financial life may indicate...